1000T Autol muscle cell therapy admn
Category III
Also known as: Autologous myoblast therapy, Muscle cell therapy
Administration of autologous muscle cell therapy. This emerging therapy involves injecting the patient's own cultured muscle cells to repair or regenerate damaged muscle tissue.
Clinical Context
Category III temporary code for investigational treatment of cardiac or skeletal muscle dysfunction. Research indicates potential use in heart failure and muscular dystrophy management.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.